Pathological and clinical effects of interleukin-6 on human myocarditis
Pathological and clinical effects of interleukin-6 on human myocarditis
复制标题
DOI:
10.1016/j.jjcc.2021.03.003
复制
发表时间:
2021-06-18
影响因子:
2.5
通讯作者:
Ito, Hiroshi
中科院分区:
文献类型:
--
作者:
Amioka, Naofumi;Nakamura, Kazufumi;Ito, Hiroshi
Background: Numerous basic studies have shown a relationship between interleukin-6 (IL-6) and the development or severity of myocarditis. However, there has been no study in which the effect of IL-6 levels in patients with myocarditis was evaluated. Methods: We enrolled control patients ( n = 12) and consecutive patients with acute myocarditis ( n = 13), including lymphocytic, eosinophilic, and giant cell myocarditis, and investigated the pathological and clinical effects of IL-6 on human myocarditis. Results: The serum IL-6 level in patients with myocarditis (16.7 [9.9, 103.8] pg/mL) was significantly higher than that in the control patients (1.4 [1.0, 1.9] pg/mL) ( P < 0.001). Immunohistochemical analysis showed that IL-6 was expressed in infiltrating inflammatory cells of endomyocardial biopsy samples from all patients with myocarditis. Moreover, the log-transformed value of serum IL-6 level showed significant positive correlations with serum creatine kinase (CK) level, CK-MB level, peak CK level, peak CK-MB level and C-reactive protein level (all P